Thu, Dec 18, 2014, 11:43 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • crecy_war_knight crecy_war_knight Jun 17, 2013 9:24 AM Flag

    I totally forgot about the glaucoma treatment...

    ACAD rose 4.1 percent to $19.31 and is up more than 700 percent since releasing positive data about its Pimavanserin drug for Parkinson's disease on Nov. 25. More recently it's been climbing on enthusiasm surrounding a potential glaucoma treatment being developed with Allergan.

32.85+1.35(+4.27%)Dec 18 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.